173 related articles for article (PubMed ID: 24031026)
1. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
[TBL] [Abstract][Full Text] [Related]
2. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
[TBL] [Abstract][Full Text] [Related]
3. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
[TBL] [Abstract][Full Text] [Related]
4. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
6. Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells.
Song JH; Lee CJ; An HJ; Yoo SM; Kang HC; Lee JY; Kim KD; Kim DJ; Lee HS; Cho YY
Mol Carcinog; 2019 Jan; 58(1):88-101. PubMed ID: 30230030
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal region of p27 inhibits HIF-1α protein translation in ribosomal protein S6-dependent manner by regulating PHLPP-Ras-ERK-p90RSK axis.
Zhang D; Liu J; Mi X; Liang Y; Li J; Huang C
Cell Death Dis; 2014 Nov; 5(11):e1535. PubMed ID: 25412313
[TBL] [Abstract][Full Text] [Related]
8. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
[TBL] [Abstract][Full Text] [Related]
9. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
10. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells.
Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S
Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
12. Molecular Targeting of ERKs/RSK2 Signaling in Cancers.
Cho YY
Curr Pharm Des; 2017 Nov; 23(29):4247-4258. PubMed ID: 28714417
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
14. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
Lee CJ; Jang JH; Lee JY; Lee MH; Li Y; Ryu HW; Choi KI; Dong Z; Lee HS; Oh SR; Surh YJ; Cho YY
Carcinogenesis; 2015 Oct; 36(10):1223-34. PubMed ID: 26243309
[TBL] [Abstract][Full Text] [Related]
15. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
Leaner VD; Donninger H; Ellis CA; Clark GJ; Birrer MJ
Mol Cell Biol; 2005 Apr; 25(8):3324-37. PubMed ID: 15798216
[TBL] [Abstract][Full Text] [Related]
16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
17. [ERK and JNK/AP-1 pathways involved in benzo(a)pyrene induced cell cycle changes in human embryo lung fibroblasts].
Gao A; Liu BC; Huang CS; Shi XL; Jia XW; You BR; Ye M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):72-6. PubMed ID: 16600107
[TBL] [Abstract][Full Text] [Related]
18. Isobavachalcone exerts anti‑proliferative and pro‑apoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway.
Li B; Xu N; Wan Z; Ma L; Li H; Cai W; Chen X; Huang Z; He Z
Oncol Rep; 2019 Jun; 41(6):3355-3366. PubMed ID: 30942462
[TBL] [Abstract][Full Text] [Related]
19. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
Kajanne R; Miettinen P; Mehlem A; Leivonen SK; Birrer M; Foschi M; Kähäri VM; Leppä S
J Cell Physiol; 2007 Aug; 212(2):489-97. PubMed ID: 17348021
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1-CDK4 in silica-induced transformed cells is due to activation of ERKs, JNKs/AP-1 pathway.
Shen F; Fan X; Liu B; Jia X; Du H; You B; Ye M; Huang C; Shi X
Toxicol Lett; 2006 Jan; 160(3):185-95. PubMed ID: 16125882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
